乌鸦传媒

Tanya Dorff, MD, reviews two prostate cancer immunotherapy studies

Ahmad Tarhini, MD, PhD, discusses some of the exciting data presented at the meeting

Retrospective analysis of Cleveland Clinic data looks to answer the question

Jun Gong, MD, says the future is bright for immunotherapy-based combinations

A phase II trial examined propranolol's effect on adrenergic stress in esophageal cancer patients

Van Karlyle Morris, MD, discusses the success of checkpoint blockade in this population

"There's going to be more immunotherapy trials coming," says Jorge Nieva, MD